Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

Phase I study found antibody activity remained high in all age groups of 33 healthy adult participants at day 209, ie 180 days after second dose of Moderna vaccine. Ongoing data will determine effect of booster dose to extend duration and breadth of activity against variants.

New England Journal of Medicine